Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ MRGPRF Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA5110966
Description
Immunogen sequence: MAGNCSWEAH PGNRNRMCPG LSEAPELYSR GFLTIEQIAM LP.
May bind to a neuropeptide and may regulate nociceptor function and/or development, including the sensation or modulation of pain. Expressed in the Gut, vas deferens, uterus and aorta; barely detectable in liver, kidney, lung, and salivary gland. In the brain, markedly abundant in the cerebellum.
Specifications
MRGPRF | |
Polyclonal | |
Unconjugated | |
MRGPRF | |
BC019711; G protein coupled receptor (RTA); G protein coupled receptor Rca; G protein-coupled receptor 140; G protein-coupled receptor 168; G protein-coupled receptor MrgF; G protein-coupled receptor RTA; G-p; GPR140; GPR168; G-protein coupled receptor 140; G-protein coupled receptor 168; G-protein coupled receptor RTA; MAS related GPR family member F; mas-related G protein-coupled MRGF; Mas-related G protein-coupled receptor c; mas-related gene; mas-related gene F protein; MAS-related GPR, member F; mas-related G-protein coupled receptor member F; MAS-related G-protein coupled receptor, member F; MGC21621; Mgrc; MRGF; MRGPRF; PSEC0142; Rta; seven transmembrane helix receptor | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
116535 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
0.1 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q96AM1 | |
MRGPRF | |
Recombinant Protein corresonding to Human MRGPRF. Recombinant protein control fragment (Product #RP-95172). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction